Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-22-004986

Chief Executive Officer gave up 8,566 shares (to pay taxes)

  • Chief Executive Officer acquired 8,716 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vounatsos Michel Chief Executive Officer 2022-02-12 Option exercise +4,321 67,987.19 D: show line 1 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Shares withheld for taxes −1,917 $214.59 $411,369 66,070.19 D: show line 2 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Option exercise +4,395 70,465.19 D: show line 3 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Shares withheld for taxes −1,950 $214.59 $418,451 68,515.19 D: show line 4 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Shares withheld for taxes −4,699 $214.59 $1,008,358 63,816.19 D: show line 5 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vounatsos Michel Chief Executive Officer 2022-02-12 Option exercise · Restricted Stock Unit −4,321 8,205 D: show line 6 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Other disposition · Restricted Stock Unit −8,205 0 D: show line 7 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Option exercise · Restricted Stock Unit −4,395 20,727 D: show line 8 in the form
Vounatsos Michel Chief Executive Officer 2022-02-12 Other disposition · Restricted Stock Unit −8,163 12,564 D: show line 9 in the form
Loading xslF345X03/form4.xml…